NCT00054353View on ClinicalTrials.gov

Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

October 31, 2009

Study Completion Date

October 14, 2012

Conditions
Refractory Multiple Myeloma
Interventions
DRUG

fludarabine phosphate

Given IV

DRUG

melphalan

Given IV

RADIATION

total-body irradiation

Undergo TBI

DRUG

mycophenolate mofetil

Given PO

DRUG

cyclosporine

Given PO

PROCEDURE

nonmyeloablative allogeneic hematopoietic stem cell transplantation

Undergo reduced-intensity allogeneic PBSCT

PROCEDURE

peripheral blood stem cell transplantation

Undergo reduced-intensity allogeneic PBSCT

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (2)

10126

University of Torino, Torino

98109

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00054353 - Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter